// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Unintended consequences: assessing adverse patient outcomes due to access restriction in a semi-rural sexual health clinic

Molly Traish - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Grab ‘n’ go: an express STI testing clinic in Scotland in response to the COVID-19 pandemic

Alexandra Maxwell - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Coronavirus disease

N/A

‘I just called to say’: results of a patient satisfaction survey evaluating the use of telemedicine for consultations within the Oxfordshire integrated sexual health service.

Matilda Kempton - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Unscheduled HIV care activity in St Mary’s Hospital during the COVID peak and lock-down period

Jennifer Dhammi - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Use and acceptability of Sexual Health London (SHL)

Laurence Dufaur - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Service users’ experiences of a large integrated sexual health (ISH) service during the SARS-CoV-2 pandemic

Jo Gibbs - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Attendance by exception: clinical safety in a national lockdown - prove it

Leanne Eddie - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

“You guys are good at swabs!” setting up a staff and patient coronavirus testing service using existing sexual health service infrastructure in a large regional teaching hospital

Ruth Taylor - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Pulmonary choriocarcinoma in an HIV infected female - is it non-gestational or metastatic, following successful treatment of hydatidiform mole?

Nikita Keswani - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Recurrent hydatidiform moles

Levonorgestrel

Management of chronic prostatitis using NICE guidelines at the John Hunter Clinic

Kaywaan Khan - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Sexually transmitted infections in England: the state of the nation

Amber Newbigging-Lister - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Real-time and enhanced surveillance of STIs in England (RESTI)

Mateo Prochazka - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Cost saving antriretroviral switch: a patient perspective

Branwen Davies - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Management training programme for GUM/HIV specialist trainees: outcome from a QIP

Hannah Pintilie - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The 11th National Genitourinary Medicine (GUM) taster day

Rebecca Marchant - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Methadone hydrochloride

What should Britain’s fourth National Survey of Sexual Attitudes and Lifestyles (Natsal-4) ask?: responses and reflections from our stakeholder consultation

Mary-Clare Ridge - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Audit of Trichomonas Vaginalis diagnosis and management in the South West of England

Alice Robertson - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Student feedback from a new interactive sexual health e-learning course is as good as the previous face-to-face teaching

Johnny Boylan - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Evaluation of the BASHH STI Foundation (STIF), intermediate course

Laura Gillespie - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Gender and sex in sexual health research: what should we measure and how? Methodological development work for Britain’s fourth National Survey of Sexual Attitudes and Lifestyles (Natsal-4)

Soazig Clifton - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved